Jeffrey J. Czajka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jeffrey J. Czajka has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Yinjie J. Tang
Department of Energy, Environmental, and Chemical Engineering, Washington University in St. Louis, 1 Brookings Drive, St. Louis, MO 63130, USA
10 shared publications - Aindrila Mukhopadhyay
Joint BioEnergy Institute, Emeryville, CA, USA
3 shared publications Chunsheng Yan
Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA
2 shared publicationsDavid Shultis
Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109, USA
2 shared publicationsFelicia Gray
Department of Pathology, University of Michigan, 1150 W. Medical Center Drive, Ann Arbor, MI 48109, USA
2 shared publications- Hector Garcia Martin
Joint BioEnergy Institute, Emeryville, CA, USA
2 shared publications
Latest Publications
- 18 March 2026
- Published by Elsevier in Bioresource Technology
- Vol. 450, 134436
Host analysis-guided selection and targeted engineering (HASTE) of Lipomyces tetrasporus for the conversion of CO2-derived feedstocks
- 18 March 2026
- Published by Elsevier in Bioresource Technology
- Vol. 450, 134436
Host analysis-guided selection and targeted engineering (HASTE) of Lipomyces tetrasporus for the conversion of CO2-derived feedstocks
- Open Access
- 23 August 2025
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 41 (9)
FluxRETAP: A REaction TArget Prioritization G e nome-Scale Modeling Technique for Selecting Genetic Targets
Motivation: Metabolic engineering is rapidly evolving as a result of new advances in synthetic biology tools and automation platforms that enable high throughput strain construction, as well as the development of machine learning tools (ML) for biology. However, selecting genetic engineering targets that effectively guide the metabolic engineering process is still challenging. ML can provide predictive power for synthetic biology, but current technical limitations prevent the independent use of ML approaches without previous biological knowledge. Results: Here, we present FluxRETAP, a simple and computationally inexpensive method that leverages the prior mechanistic knowledge embedded in genome-scale models (GSMs) for suggesting targets for genetic overexpression, downregulation or deletion, with the final goal of increasing the production of a desired metabolite. This method can provide a list of desirable engineering targets that can be combined with current ML pipelines. FluxRETAP captured 100% of reaction targets experimentally verified to improve Escherichia coli isoprenol production, 50% of targets that experimentally improved taxadiene production in E. coli and ∼60% of genetic targets from a verified minimal constrained cut-set in Pseudomonas putida, while providing additional high priority targets that could be tested. Overall, FluxRETAP is an efficient algorithm for identifying a prioritized list of testable genetic and reaction targets. Availability: FluxRETAP is implemented in python and released under the creative commons license. The implementation and code are freely available at: (https://github.com/JBEI/FluxRETAP). Supplementary information: Supplementary data are available at Bioinformatics online.
- 23 August 2025
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 41 (9)
Open AccessFluxRETAP: A REaction TArget Prioritization G e nome-Scale Modeling Technique for Selecting Genetic Targets
Motivation: Metabolic engineering is rapidly evolving as a result of new advances in synthetic biology tools and automation platforms that enable high throughput strain construction, as well as the development of machine learning tools (ML) for biology. However, selecting genetic engineering targets that effectively guide the metabolic engineering process is still challenging. ML can provide predictive power for synthetic biology, but current technical limitations prevent the independent use of ML approaches without previous biological knowledge. Results: Here, we present FluxRETAP, a simple and computationally inexpensive method that leverages the prior mechanistic knowledge embedded in genome-scale models (GSMs) for suggesting targets for genetic overexpression, downregulation or deletion, with the final goal of increasing the production of a desired metabolite. This method can provide a list of desirable engineering targets that can be combined with current ML pipelines. FluxRETAP captured 100% of reaction targets experimentally verified to improve Escherichia coli isoprenol production, 50% of targets that experimentally improved taxadiene production in E. coli and ∼60% of genetic targets from a verified minimal constrained cut-set in Pseudomonas putida, while providing additional high priority targets that could be tested. Overall, FluxRETAP is an efficient algorithm for identifying a prioritized list of testable genetic and reaction targets. Availability: FluxRETAP is implemented in python and released under the creative commons license. The implementation and code are freely available at: (https://github.com/JBEI/FluxRETAP). Supplementary information: Supplementary data are available at Bioinformatics online.
- Open Access
- 13 September 2022
- Published by Elsevier in Metabolic Engineering Communications
- Vol. 15, e00206
Tuning a high performing multiplexed-CRISPRi Pseudomonas putida strain to further enhance indigoidine production
- 13 September 2022
- Published by Elsevier in Metabolic Engineering Communications
- Vol. 15, e00206
Open AccessTuning a high performing multiplexed-CRISPRi Pseudomonas putida strain to further enhance indigoidine production
- Open Access
Optimizing a High Performing Multiplex-CRISPRi P. putida Strain with Integrated Metabolomics and 13 C-Metabolic Flux Analyses
Microbial cell factory development often faces bottlenecks after initial rounds of design-build-test-learn (DBTL) cycles as engineered producers respond unpredictably to further genetic modifications. Thus, deciphering metabolic flux and correcting bottlenecks are key components of DBTL cycles. Here, a 14-gene edited Pseudomonas putida KT2440 strain for heterologous indigoidine production was examined using both 13 C–metabolic flux analysis ( 13 C–MFA) and metabolite measurements. The results indicated the conservation of the cyclic Entner-Doudoroff (ED)-EMP pathway flux, downregulation of the TCA cycle and pyruvate shunt, and glyoxylate shunt activation. At the metabolite level, the CRISPR/dCpf1-interference mediated multiplex repression decreased gluconate/2-ketogluconate secretion and altered several intracellular TCA metabolite concentrations, leading to succinate overflow. Further strain engineering based on the metabolic knowledge first employed an optimal ribosome binding site (RBS) to achieve stronger product-substrate growth coupling (1.6–fold increase). Then, deletion strains were constructed using ssDNA recombineering. Of the five strains tested, deletion of the PHA operon (Δ phaAZC-IID ) resulted in a 2.2–fold increase in growth phase production compared to the optimal RBS construct. After 72 h of batch cultivation, the Δ phaAZC-IID strain had 1.5–fold and 1.8–fold increases of indigoidine titer compared to the improved RBS construct and the original strain, respectively. Overall, the findings provided actionable DBTL targets as well as insights into physiological responses and flux buffering when new recombineering tools were used for engineering P. putida KT2440.
Open AccessOptimizing a High Performing Multiplex-CRISPRi P. putida Strain with Integrated Metabolomics and 13 C-Metabolic Flux Analyses
Microbial cell factory development often faces bottlenecks after initial rounds of design-build-test-learn (DBTL) cycles as engineered producers respond unpredictably to further genetic modifications. Thus, deciphering metabolic flux and correcting bottlenecks are key components of DBTL cycles. Here, a 14-gene edited Pseudomonas putida KT2440 strain for heterologous indigoidine production was examined using both 13 C–metabolic flux analysis ( 13 C–MFA) and metabolite measurements. The results indicated the conservation of the cyclic Entner-Doudoroff (ED)-EMP pathway flux, downregulation of the TCA cycle and pyruvate shunt, and glyoxylate shunt activation. At the metabolite level, the CRISPR/dCpf1-interference mediated multiplex repression decreased gluconate/2-ketogluconate secretion and altered several intracellular TCA metabolite concentrations, leading to succinate overflow. Further strain engineering based on the metabolic knowledge first employed an optimal ribosome binding site (RBS) to achieve stronger product-substrate growth coupling (1.6–fold increase). Then, deletion strains were constructed using ssDNA recombineering. Of the five strains tested, deletion of the PHA operon (Δ phaAZC-IID ) resulted in a 2.2–fold increase in growth phase production compared to the optimal RBS construct. After 72 h of batch cultivation, the Δ phaAZC-IID strain had 1.5–fold and 1.8–fold increases of indigoidine titer compared to the improved RBS construct and the original strain, respectively. Overall, the findings provided actionable DBTL targets as well as insights into physiological responses and flux buffering when new recombineering tools were used for engineering P. putida KT2440.
- 1 September 2021
- Published by Elsevier in Metabolic Engineering
- Vol. 67, 227-236
Integrated knowledge mining, genome-scale modeling, and machine learning for predicting Yarrowia lipolytica bioproduction
- 1 September 2021
- Published by Elsevier in Metabolic Engineering
- Vol. 67, 227-236
Integrated knowledge mining, genome-scale modeling, and machine learning for predicting Yarrowia lipolytica bioproduction
- 13 April 2020
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 64, 134-140
Biosynthesis of terpene compounds using the non-model yeast Yarrowia lipolytica: grand challenges and a few perspectives
- 13 April 2020
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 64, 134-140
Biosynthesis of terpene compounds using the non-model yeast Yarrowia lipolytica: grand challenges and a few perspectives
- 1 September 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 55, 120-130
A concerted systems biology analysis of phenol metabolism in Rhodococcus opacus PD630
- 1 September 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 55, 120-130
A concerted systems biology analysis of phenol metabolism in Rhodococcus opacus PD630
- 1 July 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 54, 222-231
Cyanobacterial carboxysome mutant analysis reveals the influence of enzyme compartmentalization on cellular metabolism and metabolic network rigidity
- 1 July 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 54, 222-231
Cyanobacterial carboxysome mutant analysis reveals the influence of enzyme compartmentalization on cellular metabolism and metabolic network rigidity
- 1 February 2019
- Published by Elsevier in Journal of Molecular Biology
- Vol. 431 (4) , 825-841
Changing the Apoptosis Pathway through Evolutionary Protein Design
- 1 February 2019
- Published by Elsevier in Journal of Molecular Biology
- Vol. 431 (4) , 825-841
Changing the Apoptosis Pathway through Evolutionary Protein Design